Dahl G - Search Results

1

The Vital Role of Proteomics in Characterizing Novel Protein Degraders.

Zhang AX, Cassidy K, Dahl G, Moreau K, Pachl F, Zuhl AM. Zhang AX, et al. Among authors: dahl g. SLAS Discov. 2021 Apr;26(4):518-523. doi: 10.1177/2472555220985776. Epub 2021 Feb 20. SLAS Discov. 2021. PMID: 33615886 Free article. Review.

2

Proteolysis-targeting chimeras in drug development: A safety perspective.

Moreau K, Coen M, Zhang AX, Pachl F, Castaldi MP, Dahl G, Boyd H, Scott C, Newham P. Moreau K, et al. Among authors: dahl g. Br J Pharmacol. 2020 Apr;177(8):1709-1718. doi: 10.1111/bph.15014. Epub 2020 Feb 25. Br J Pharmacol. 2020. PMID: 32022252 Free PMC article. Review.

3

Regenerable Biosensors for Small-Molecule Kinetic Characterization Using SPR.

Gunnarsson A, Stubbs CJ, Rawlins PB, Taylor-Newman E, Lee WC, Geschwindner S, Hytönen V, Holdgate G, Jha R, Dahl G. Gunnarsson A, et al. Among authors: dahl g. SLAS Discov. 2021 Jun;26(5):730-739. doi: 10.1177/2472555220975358. Epub 2020 Dec 8. SLAS Discov. 2021. PMID: 33289457 Free article.

4

Pharmacokinetics and the drug-target residence time concept.

Dahl G, Akerud T. Dahl G, et al. Drug Discov Today. 2013 Aug;18(15-16):697-707. doi: 10.1016/j.drudis.2013.02.010. Epub 2013 Mar 14. Drug Discov Today. 2013. PMID: 23500610 Review.

5

Unified Software Solution for Efficient SPR Data Analysis in Drug Research.

Dahl G, Steigele S, Hillertz P, Tigerström A, Egnéus A, Mehrle A, Ginkel M, Edfeldt F, Holdgate G, O'Connell N, Kappler B, Brodte A, Rawlins PB, Davies G, Westberg EL, Folmer RH, Heyse S. Dahl G, et al. SLAS Discov. 2017 Feb;22(2):203-209. doi: 10.1177/1087057116675316. Epub 2016 Oct 28. SLAS Discov. 2017. PMID: 27789754 Free PMC article.

6

A Comparative Study of Fluorescence Assays in Screening for BRD4.

Hansson P, Boyd H, Dale IL, Dahl G, Nicolaus F, Bowen W, Doering K, Dunsmore C, Cotton G, Lindmark H. Hansson P, et al. Among authors: dahl g. Assay Drug Dev Technol. 2018 Oct;16(7):372-383. doi: 10.1089/adt.2018.850. Epub 2018 Oct 9. Assay Drug Dev Technol. 2018. PMID: 30307314

7

Inhibition of low-density lipoprotein receptor degradation with a cyclic peptide that disrupts the homodimerization of IDOL E3 ubiquitin ligase.

Leitch EK, Elumalai N, Fridén-Saxin M, Dahl G, Wan P, Clarkson P, Valeur E, Pairaudeau G, Boyd H, Tavassoli A. Leitch EK, et al. Among authors: dahl g. Chem Sci. 2018 Jun 26;9(27):5957-5966. doi: 10.1039/c8sc01186a. eCollection 2018 Jul 21. Chem Sci. 2018. PMID: 30079210 Free PMC article.

8

A comprehensive company database analysis of biological assay variability.

Kramer C, Dahl G, Tyrchan C, Ulander J. Kramer C, et al. Among authors: dahl g. Drug Discov Today. 2016 Aug;21(8):1213-21. doi: 10.1016/j.drudis.2016.03.015. Epub 2016 Apr 7. Drug Discov Today. 2016. PMID: 27063506 Review.

9

Structure and biophysical characterization of the human full-length neurturin-GFRa2 complex: A role for heparan sulfate in signaling.

Sandmark J, Dahl G, Öster L, Xu B, Johansson P, Akerud T, Aagaard A, Davidsson P, Bigalke JM, Winzell MS, Rainey GJ, Roth RG. Sandmark J, et al. Among authors: dahl g. J Biol Chem. 2018 Apr 13;293(15):5492-5508. doi: 10.1074/jbc.RA117.000820. Epub 2018 Feb 2. J Biol Chem. 2018. PMID: 29414779 Free PMC article.

10

Cryo-EM structure of the activated RET signaling complex reveals the importance of its cysteine-rich domain.

Bigalke JM, Aibara S, Roth R, Dahl G, Gordon E, Dorbéus S, Amunts A, Sandmark J. Bigalke JM, et al. Among authors: dahl g. Sci Adv. 2019 Jul 31;5(7):eaau4202. doi: 10.1126/sciadv.aau4202. eCollection 2019 Jul. Sci Adv. 2019. PMID: 31392261 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

559 results

Search Page